Actively Recruiting
Registry of Acute Myocardial Infarction
Led by Tomsk National Research Medical Center of the Russian Academy of Sciences · Updated on 2025-04-09
97500
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
T
Tomsk National Research Medical Center of the Russian Academy of Sciences
Lead Sponsor
W
World Health Organization
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are collecting detailed information about acute myocardial infarction (AMI), also known as a heart attack, in residents and visitors of Tomsk, Russian Federation. This observational study uses worldwide standard diagnostic criteria recommended by the World Health Organization to identify and classify AMI cases. The goal is to monitor the occurrence and outcomes of AMI, including recording confirmed and suspected cases, and analyzing disease patterns over time. The study gathers data from all medical institutions that document suspected or confirmed AMI cases. Information is entered into a specialized registration card and stored in a secure, web-accessible database designed for statistical analysis. Cases are categorized after 28 days from disease onset into definite, possible, unconfirmed, or insufficient data groups based on clinical, biochemical, electrocardiographic, and autopsy findings. Annual reports summarize key measures like incidence, mortality, and lethality rates. Participants are monitored through routine medical care with data collected centrally. Researchers review early AMI lethality within 28 days and also track lethality at 12 months as primary and secondary outcome measures. The study started in 1984 and continues to collect data long-term. The registry provides comprehensive epidemiological information by analyzing all reported AMI cases in the local population over time.
CONDITIONS
Brief Title
Registry of Acute Myocardial Infarction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age of at least 20 years
- Resident or visitor of the city of Tomsk at the time of AMI onset
- Diagnosis of definite or possible acute myocardial infarction based on ECG changes, typical pain syndrome, enzyme levels, or coronary artery obstruction
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 28 days after disease onset
Participants undergo diagnostic procedures including clinical, biochemical, electrocardiographic, and autopsy assessments to confirm acute myocardial infarction.
1 to 2 visits depending on diagnostic procedures
Duration - Up to 12 months
Participants are monitored to assess disease outcomes including morbidity, mortality, and lethality rates over time.
Follow-up visits as per registry data collection
Trial Site Locations
Total: 1 location
1
Tomsk National Research Medical Center, Russian Academy of Sciences
Tomsk, Russia
Actively Recruiting
Research Team
S
Sergey A. Okrugin, MD, PhD
N
Nina D. Anfinogenova, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here